News on lab-developed tests and emerging diagnostic technologies.
Layoffs at Life Science, Dx Firms Continue as Thermo Fisher Scientific, Natera Shrink Payrolls
In 2023, Thermo Fisher has laid off nearly 400 California employees at sites associated with Mesa Biotech, acquired in 2021 for $450 million in cash.
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.
Guardant Health, Ohio State University Partner on Blood-Based Colon Cancer Screening Study
OSU investigators will offer the Guardant Shield assay to patients via mobile phlebotomists, studying adoption rates among approximately 300 individuals.
Invitae, Epic Sign Deal to Integrate Genetic Test Results Into EMR System
Invitae said results from its genetic tests would be made available directly to healthcare providers using Epic's electronic medical record systems.
LumiraDx Q4 Revenues Fall 65 Percent
The company was impacted by a $96.3 million accounting impairment due to excess manufacturing and inventory related to its COVID-19 test scale-up.